| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A critical update on prognostic and predictive biomarkers in malignant pleural mesothelioma
|
Ghanim, Bahil
|
|
2014
|
8 |
1 |
p. 52-56
|
article
|
| 2 |
Beyond R-CHOP: treatment of double hit, tripple hit, MYC + NHL?
|
Fridrik, Michael A.
|
|
2015
|
8 |
1 |
p. 48-51
|
article
|
| 3 |
Clinical update: B-cell receptor kinase inhibitors in chronic lymphocytic leukemia
|
Weiss, Lukas
|
|
2014
|
8 |
1 |
p. 38-42
|
article
|
| 4 |
High-dose chemotherapy and autologous hematopoietic stem cell transplantation in a myeloma patient with terminal renal failure and hepatitis C with high viral load
|
Zojer, Niklas
|
|
2015
|
8 |
1 |
p. 35-37
|
article
|
| 5 |
Is dosing in oncology gender-sensitive?
|
Marosi, Christine
|
|
2014
|
8 |
1 |
p. 5-10
|
article
|
| 6 |
Is more better in myeloma? Treatment intensity and outcome in newly diagnosed myeloma patients
|
Fillitz, Michael
|
|
2015
|
8 |
1 |
p. 22-25
|
article
|
| 7 |
Lymphoma: anything new?
|
Gunsilius, Eberhard
|
|
2015
|
8 |
1 |
p. 3-4
|
article
|
| 8 |
Multiple myeloma: the biology, the clinic, and the future
|
Zojer, Niklas
|
|
2015
|
8 |
1 |
p. 1-2
|
article
|
| 9 |
New drugs on the horizon. Treatment of myeloma in 2020, a perspective
|
Ludwig, Heinz
|
|
2015
|
8 |
1 |
p. 16-21
|
article
|
| 10 |
Optimal follow-up of cervical cancer patients
|
Vrdoljak, Eduard
|
|
2015
|
8 |
1 |
p. 66-70
|
article
|
| 11 |
Optimal follow-up of endometrial cancer patients
|
Vrdoljak, Eduard
|
|
2015
|
8 |
1 |
p. 62-65
|
article
|
| 12 |
Optimal follow-up of ovarian cancer patients
|
Vrdoljak, Eduard
|
|
2014
|
8 |
1 |
p. 57-61
|
article
|
| 13 |
PET in lymphoma: who, when, how often, pitfalls?
|
Uprimny, Christian
|
|
2014
|
8 |
1 |
p. 43-47
|
article
|
| 14 |
Predicting drug sensitivity by 3D cell culture models
|
Amann, Arno
|
|
2015
|
8 |
1 |
p. 77-80
|
article
|
| 15 |
Radiotherapy for brain metastases: are we getting better?
|
Zach, Leor
|
|
2014
|
8 |
1 |
p. 71-76
|
article
|
| 16 |
Tailoring treatment in myeloma: are there clues from biology?
|
Zojer, Niklas
|
|
2015
|
8 |
1 |
p. 11-15
|
article
|
| 17 |
To maintain or not to maintain: treatment forever in myeloma?
|
Willenbacher, Wolfgang
|
|
2014
|
8 |
1 |
p. 26-29
|
article
|
| 18 |
Treatment of myeloma patients with renal impairment
|
Lechner, Daniel
|
|
2014
|
8 |
1 |
p. 30-34
|
article
|
Journal description